Detalhe da pesquisa
1.
Enhancing global access to cancer medicines.
CA Cancer J Clin
; 70(2): 105-124, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32068901
2.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
N Engl J Med
; 388(18): 1645-1656, 2023 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37133584
3.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35139274
4.
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Lancet Oncol
; 24(8): e331-e343, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37541279
5.
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lancet Oncol
; 24(1): e11-e56, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36400101
6.
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey.
Oncologist
; 28(10): 856-865, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37523663
7.
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
Oncologist
; 28(10): e877-e883, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37310797
8.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med
; 382(9): 810-821, 2020 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32101663
9.
Well-being trajectories in breast cancer and their predictors: A machine-learning approach.
Psychooncology
; 32(11): 1762-1770, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37830776
10.
Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer.
Breast J
; 2022: 9921575, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36474966
11.
3D Breast Volume Estimation.
Eur Surg Res
; 63(1): 3-8, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34038908
12.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33721561
13.
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.
Lancet Oncol
; 22(1): e18-e28, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33387500
14.
Cognitive, emotional, and behavioral mediators of the impact of coping self-efficacy on adaptation to breast cancer: An international prospective study.
Psychooncology
; 30(9): 1555-1562, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33998100
15.
The Lancet Breast Cancer Commission.
Lancet
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38636533
16.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-27557300
17.
Male breast cancer: a disease distinct from female breast cancer.
Breast Cancer Res Treat
; 173(1): 37-48, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30267249
18.
A rude awakening from tumour cells.
Nature
; 554(7690): 35-36, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29388969
19.
A rude awakening from tumour cells.
Nature
; 554(7690): 35-36, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32094835
20.
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Lancet Oncol
; 19(3): 323-336, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29433963